Our Science


Motolimod appears to work synergistically with certain types of chemotherapy to stimulate an immune response in the tumor. Motolimod also enhances the anti-tumor effect of monoclonal antibodies by stimulating natural killer (NK) cells and an immune process known as antibody dependent cellular toxicity (ADCC).

VentiRx's Motolimod Stimulates an Immune Response in the Tumor